Meanwhile, several NSAIDs, such as sodium salicylate, celecoxib, aspirin, and diclofenac, have been found to exert a neuroprotective role by decreasing NF-kB expression in an MPTP-induced model of PD (Bassani et al., 2015). Here, NFKB1 is linked to Parkinson disease.